Delivery Order 36F79723D0079-36C25624N0480
- The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed price delivery order to Ferring Pharmaceuticals Inc. for the oncology medication Adstiladrin (Nadofaragene Firadenovec) under the company's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. This $45,829.15 order will support the VA's provision of healthcare services to veterans through its integrated network of medical centers and clinics nationwide. Ferring, a research-driven specialty biopharmaceutical...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Ferring Pharmaceuticals Inc., a for-profit manufacturer, to provide the oncology medication Adstiladrin (nadofaragene firadenovec) under the agency's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $45,829.15 firm-fixed price order is for delivery by December 31, 2024 to support the VA's provision of healthcare services to veterans through its integrated network of...
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency, to Avadel CNS Pharmaceuticals, LLC, doing business as Avadel Pharmaceuticals, a foreign-owned for-profit organization. The contract has a ceiling value of $11,197.82 and is set to expire on September 30, 2025. It is not associated with a set-aside program. The contract was awarded on August 25, 2025 and is under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $45,829.15 firm fixed price delivery order contract to Ferring Pharmaceuticals Inc. under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The contract is for the emergency procurement of Adstiladrin to be delivered to a location in Carrollton, Texas between November 8 and December 7, 2023. No set aside designation or subcontractors were indicated. The...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 9 (VISN 9) awarded a $7,237.08 firm-fixed-price purchase order to Scpharmaceuticals Inc., a for-profit pharmaceutical company based in Lexington, MA. The order is for emergency supplies of the company's FUROSCIX furosemide medication to be delivered to the Nashville VA Medical Center. This award was not set aside and does not involve any subcontractors. Scpharmaceuticals Inc. has been...
- This federal contract award was made by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $33,838.23, is for the delivery of the drug Fabhalta 200 mg under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract is a firm fixed-price delivery order with a completion date of May 29, 2025....
- This federal contract award is for "EMERGENCY LYMYRZ" and was issued by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency. The contract was awarded to Avadel CNS Pharmaceuticals, LLC, a for-profit, foreign-owned organization, on September 22, 2025 as a Firm Fixed Price Delivery Order with a ceiling value of $11,197.82 and a completion date of September 30, 2025. The contract is not set aside and is under the Pharmaceuticals and Drugs Federal Supply Schedule...
- This federal contract award, valued at $98,745.48, was issued by the Veterans Integrated Service Network 20, a component of the U.S. Department of Veterans Affairs (VA), to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The contract is a delivery order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the VA, which has a total potential value of $219,108,390 from August 2024 to July 2029. This delivery order is for the provision of...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $45.8K to Ferring Pharmaceuticals Inc. for the supply of Adstiladrin (nadofaragene firadenovec), an oncology medication used to treat genitourinary cancers in veterans. The contract, awarded on October 17, 2025, carries a firm-fixed price structure with an ultimate completion date of October 21, 2025, and will be performed at Ferring's location in Carrollton, TX. This...
- This is a $351,244.44 firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The order is for specialty medication, primarily treatments for pulmonary arterial hypertension, which are critical drugs for VA medical centers and other federal healthcare facilities. The contract is placed against Actelion's $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79723D0079Federal Supply Schedule
- 36F79723D0079-36C25624N0480Delivery Order
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 16 awarded a $10,891.30 firm fixed price delivery order to Fennec Pharmaceuticals, Inc. on January 4, 2024. This order, which had no set-aside designation, is for the STRATUS TURN SYSTEM to support health programs for veterans in the Biloxi, Mississippi area. The period of performance ends on May 4, 2024. Fennec Pharmaceuticals, Inc. is a foreign-owned, for-profit pharmaceutical company that holds two federal supply schedule (FSS) contracts with the VA. The first is a multiple-award FSS contract (36F79723D0079) with a $1,500,000 ceiling value that covers drugs, pharmaceuticals, and hematology-related products. The second is an interim FSS agreement (36F79723D006E) with a $25,000 ceiling. Both contracts are intended to ensure VA medical centers and clinics have reliable access to necessary pharmaceuticals and support the VHA's objective of providing veterans with timely access to needed medical treatments and therapies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 1/4/24 |